Table 2:
No. | |
---|---|
Referred for embolization | 224 |
Successful embolization (%) | 177 (79.0) |
Method of embolization | |
PVA (%) | 67 (39.0) |
PVA and Gelfoam (%) | 75 (43.6) |
PVA and coil (%) | 26 (15.1) |
Coil (%) | 3 (1.7) |
PVA and Gelfoam and coil (%) | 1 (0.6) |
Embolized vessel | |
Middle meningeal | 157 (67.4) |
Occipital | 21 (9.0) |
Internal maxillary | 14 (6.0) |
Superficial temporal | 14 (6.0) |
Deep temporal branch | 13 (5.6) |
Ascending pharyngeal | 6 (2.6) |
Posterior auricular | 1 (0.4) |
Sphenopalatine | 3 (1.3) |
Meningohypophyseal trunk | 1 (0.4) |
Anterior cerebral artery branch | 1 (0.4) |
Middle cerebral artery branch | 1 (0.4) |
Vertebral artery branch | 1 (0.4) |
Tumor devascularization | |
>75% | 107 (68.6) |
50%–74% | 27 (17.3) |
25%–49% | 12 (7.7) |
<25% | 10 (6.4) |
Mean time from embolization to surgery (days) (range) | 1.6 (0–31) |
Complications | |
Dissection | 2 (1.1) |
Facial nerve palsy | 1 (0.6) |
Stroke | 1 (0.6) |
Scalp infarction | 1 (0.6) |
Iodine allergy | 1 (0.6) |